BDNF and depressive symptom measurement: In addition to the monoaminergic pathway and BDNF, other mechanisms that may be involved in depression have been reported, such as the GABAergic system alteration, increased expression of postsynaptic serotonin receptors (5-HT1A), decreased calcium influx and increased expression of astrocytes.